NUSX builds the path from breakthrough research to global venture — through programmes that build founders, infrastructure that builds companies, and partnerships that connect both to capital.
Flagship event · Sep 2026
Asia's deep-tech showcase. Three days where the founders, investors, and operators building Asia's next category-defining ventures gather in Singapore.
Demo pitches from NUS-linked startups, deep-tech showcases across AI, biotech, climate, and hardware, and curated investor briefings — all under one roof.
Mission
NUSX is the interface between Singapore's deepest research, its boldest founders, and the capital that scales them. We exist to turn breakthrough science into ventures the world can't ignore.
We do this through programmes that build founders, infrastructure that builds companies, and partnerships that connect both to global markets.
Strategic tracks
NUSX concentrates capital, talent, and partnerships across four deep-tech domains — chosen for their scientific depth, market traction, and strategic importance to Singapore.
Advanced materials, manufacturing, and physical sciences — from quantum to hard tech.
AI, software, and digital infrastructure — the intelligence layer of the new economy.
Life sciences, medtech, and biotech — turning NUS research into health breakthroughs.
Climate, energy, and sustainability — ventures built for a world under pressure.
NUSX serves three distinct audiences. Pick the one that fits where you are now.
Build a venture before you graduate. Live inside the world's leading startup ecosystems. Join a network of NUS founders shipping real products.
Explore programmes →Turn your research into a venture, a license, or an industry partnership. NUSX handles the path from lab to market — patents, programmes, capital, and named experts at every step.
Start commercialising →License breakthrough technologies, partner on sponsored research, or invest in deep-tech ventures already in motion. Browse the portfolio, meet our researchers, engage on commercial terms.
Partner or invest →Mei Lin started her quantum-secure messaging company in her final year at NUS. Three years later, she's closing a Series B with investors who found her through the BLOCK71 network.
Read the story →A partnership between NUS Medicine and the GRIP programme that turned three years of lab research into a Series A-backed diagnostics company.
Read the story →Access to deep tech research, a founder network, and a government that moves fast on climate. She explains why BLOCK71 was the right bet.
Read the story →14 Dec
Twelve early-stage deep-tech ventures present to investors, operators, and the NUS research community.
View event →22 Dec
Quarterly update for NUSX portfolio investors. Metrics, milestones, and selected founder spotlights.
View event →14 Dec
An open tour of the i3 building — NUS's flagship startup hub. Meet resident founders and see the space.
View event →Stay updated
New ventures, programme intakes, and breakthroughs from the NUS research base. No fluff, no marketing emails.